Biotech

Category / Pharmaceuticals & Biotech / Biotech

Functional Technologies Grants Options

VANCOUVER, BRITISH COLUMBIA: ...

Pacgen Reports Annual Financial Results

VANCOUVER, BRITISH COLUMBIA: ...

biOasis Announces Acquisition of Intellectual Property

VANCOUVER, BRITISH COLUMBIA: ...

New Hope for Immune Therapy for Children and Young Adults With Type 1 Diabetes: Founder of Orban Biotech's Landmark Findings for Abatacept Published in The Lancet

BROOKLINE, MA: Orban Biotech to Evaluate the Combination of Its Vaccine for Type 1 Diabetes With Abatacept ...

Securityholder Meeting in Connection with Privatization of Ondine and Debt Financing

VANCOUVER, BRITISH COLUMBIA: ...

Cytokinetics to Present at 31st Annual Canaccord Genuity Growth Conference

SOUTH SAN FRANCISCO, CA: ...

Sirona Biochem Proudly Supports Canadian Diabetes Association

VANCOUVER, BRITISH COLUMBIA: ...

Notice of Paladin Labs' First Quarter 2011 Results Conference Call

MONTREAL, CANADA: ...

Allon Granted U.S. Patent for Davunetide as a Treatment for Schizophrenia

VANCOUVER, BRITISH COLUMBIA: ...

PharmaGap Completes $496,405 Private Placement

OTTAWA, ONTARIO: ...

Cornerstone Therapeutics Reports Second Quarter 2011 Financial Results

CARY, NC: ...

Warnex Provides Update on Agreement to Extend Maturity Dates for All Outstanding Debentures

LAVAL, QUEBEC: ...

POR Launches PharmaCONNECT

BEDFORD, NH: A Real-Time On-Demand Engagement Platform Between Doctors and Pharmaceutical Brands ...

Celsion Corporation to Hold Second Quarter 2011 Financial Results Conference Call on Tuesday, August 9, 2011

COLUMBIA, MD: ...

Gentel Announces Agreement to License B Virus Antigen From National B Virus Resource Center

MADISON, WI: ...

Easton Pharmaceuticals Announces Update On Patents

TORONTO, ONTARIO: ...

AdvantageMS Announces Partnership With Global CRM Leader for Improved Biopharma Sales Force Effectiveness

FORT WASHINGTON, PA: AdvantageMS Joins Forces With StayinFront to Improve Data Quality and Master Data Management for Life Sciences Organization ...

Cerecor Announces the Appointment of Sol Barer, Ph.D. to Its Board of Directors

BALTIMORE, MD: ...

With Contracts and IND Application in Hand, Cellceutix Nears Clinical Trials for New Cancer Drug

BEVERLY, MA: ...

MOgene, LC, a Leading Genomics Service Company, to Offer 454 GS FLX+ Option for High-Quality, Sanger-Like Reads With the Power of Next-Generation Throughput

ST. LOUIS, MO: ...

Page 246 von 247: 1 « .. 243 244 245 246 247

All members:	10 563
Register today:	2
Register yesterday:	2
Members online:	0
Guests online:	99

Biotech

Category / Pharmaceuticals & Biotech / Biotech

Functional Technologies Grants Options

Pacgen Reports Annual Financial Results

biOasis Announces Acquisition of Intellectual Property

New Hope for Immune Therapy for Children and Young Adults With Type 1 Diabetes: Founder of Orban Biotech's Landmark Findings for Abatacept Published in The Lancet

Securityholder Meeting in Connection with Privatization of Ondine and Debt Financing

Cytokinetics to Present at 31st Annual Canaccord Genuity Growth Conference

Sirona Biochem Proudly Supports Canadian Diabetes Association

Notice of Paladin Labs' First Quarter 2011 Results Conference Call

Allon Granted U.S. Patent for Davunetide as a Treatment for Schizophrenia

PharmaGap Completes $496,405 Private Placement

Cornerstone Therapeutics Reports Second Quarter 2011 Financial Results

Warnex Provides Update on Agreement to Extend Maturity Dates for All Outstanding Debentures

POR Launches PharmaCONNECT

Celsion Corporation to Hold Second Quarter 2011 Financial Results Conference Call on Tuesday, August 9, 2011

Gentel Announces Agreement to License B Virus Antigen From National B Virus Resource Center

Easton Pharmaceuticals Announces Update On Patents

AdvantageMS Announces Partnership With Global CRM Leader for Improved Biopharma Sales Force Effectiveness

Cerecor Announces the Appointment of Sol Barer, Ph.D. to Its Board of Directors

With Contracts and IND Application in Hand, Cellceutix Nears Clinical Trials for New Cancer Drug

MOgene, LC, a Leading Genomics Service Company, to Offer 454 GS FLX+ Option for High-Quality, Sanger-Like Reads With the Power of Next-Generation Throughput

Service Menu

New here

Who is online